Natriuretic Peptides in Congestive Heart Failure

January 14th, 2016

BNP use as a lab and therapeutic are discussed. The episode also explores the PARADIGM-HF trial and Neprilysin inhibition. The novel combination medication sacubitril/valsartan (Entresto) for systolic CHF is evaluated in depth. Clinical tips for avoiding angioedema and other clinical pearls are provided.

Share | Download(Loading)
Podbean App

Play this podcast on Podbean App